192 related articles for article (PubMed ID: 26654776)
1. β-Glucan-based cream (containing pleuran isolated from pleurotus ostreatus) in supportive treatment of mild-to-moderate atopic dermatitis.
Jesenak M; Urbancek S; Majtan J; Banovcin P; Hercogova J
J Dermatolog Treat; 2016 Aug; 27(4):351-4. PubMed ID: 26654776
[TBL] [Abstract][Full Text] [Related]
2. A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.
Licari A; Ruffinazzi G; DE Filippo M; Castagnoli R; Marseglia A; Agostinis F; Puviani M; Milani M; Marseglia GL
Minerva Pediatr; 2017 Dec; 69(6):470-475. PubMed ID: 29181960
[TBL] [Abstract][Full Text] [Related]
3. Novel topical agent containing superoxide dismutase 100 000 IU and 4% of plant extracts as a mono-therapy for atopic dermatitis.
Sgouros D; Katoulis A; Rigopoulos D
J Cosmet Dermatol; 2018 Dec; 17(6):1069-1072. PubMed ID: 29134748
[TBL] [Abstract][Full Text] [Related]
4. Treatment of atopic dermatitis with KAM-3008, a barrier-based, non-steroidal topical cream.
Bomstein Y; Rozenblat S
J Dermatolog Treat; 2015 Oct; 26(5):426-30. PubMed ID: 25893370
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial.
Lee YW; Won CH; Jung K; Nam HJ; Choi G; Park YH; Park M; Kim B
Br J Dermatol; 2019 May; 180(5):1030-1038. PubMed ID: 30623408
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory effect of pleuran (β-glucan from Pleurotus ostreatus) in children with recurrent respiratory tract infections.
Jesenak M; Majtan J; Rennerova Z; Kyselovic J; Banovcin P; Hrubisko M
Int Immunopharmacol; 2013 Feb; 15(2):395-9. PubMed ID: 23261366
[TBL] [Abstract][Full Text] [Related]
7. Spotlight on topical pimecrolimus in atopic dermatitis.
Wellington K; Jarvis B
Am J Clin Dermatol; 2002; 3(6):435-8. PubMed ID: 12113651
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial.
Mehrbani M; Choopani R; Fekri A; Mehrabani M; Mosaddegh M; Mehrabani M
J Ethnopharmacol; 2015 Aug; 172():325-32. PubMed ID: 26151244
[TBL] [Abstract][Full Text] [Related]
9. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
Wellington K; Jarvis B
Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
[TBL] [Abstract][Full Text] [Related]
10. Patient acceptability, efficacy, and skin biophysiology of a cream and cleanser containing lipid complex with shea butter extract versus a ceramide product for eczema.
Hon KL; Tsang YC; Pong NH; Lee VW; Luk NM; Chow CM; Leung TF
Hong Kong Med J; 2015 Oct; 21(5):417-25. PubMed ID: 26314567
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
Eberlein B; Eicke C; Reinhardt HW; Ring J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
[TBL] [Abstract][Full Text] [Related]
12. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis.
Herzog JL; Solomon JA; Draelos Z; Fleischer A; Stough D; Wolf DI; Abramovits W; Werschler W; Green E; Duffy M; Rothaul A; Tansley R
J Drugs Dermatol; 2011 Aug; 10(8):853-60. PubMed ID: 21818506
[TBL] [Abstract][Full Text] [Related]
14. A 1% Colloidal Oatmeal Cream Alone is Effective in Reducing Symptoms of Mild to Moderate Atopic Dermatitis: Results from Two Clinical Studies.
Lisante TA; Nunez C; Zhang P; Mathes BM
J Drugs Dermatol; 2017 Jul; 16(7):671-676. PubMed ID: 28697218
[TBL] [Abstract][Full Text] [Related]
15. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
16. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
Szczepanowska J; Reich A; Szepietowski JC
Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled, double-blind clinical study evaluating the safety and efficacy of MD2011001 cream in mild-to-moderate atopic dermatitis of the face and neck in children, adolescents and adults.
Patrizi A; Raone B; Neri I; Gurioli C; Carbonara M; Cassano N; Vena GA
J Dermatolog Treat; 2016 Aug; 27(4):346-50. PubMed ID: 26652026
[TBL] [Abstract][Full Text] [Related]
18. Case study of clinical improvement of atopic dermatitis in a patient treated with herbal-based parapharmaceuticals.
Maraschio A; Wulhfard K; Monsellato L
J Complement Integr Med; 2023 Jun; 20(2):504-511. PubMed ID: 37043584
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies.
Papp K; Szepietowski JC; Kircik L; Toth D; Eichenfield LF; Leung DYM; Forman SB; Venturanza ME; Sun K; Kuligowski ME; Simpson EL
J Am Acad Dermatol; 2021 Oct; 85(4):863-872. PubMed ID: 33957195
[TBL] [Abstract][Full Text] [Related]
20. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial.
Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
